Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169

Author:

Gemenetzi Katerina12ORCID,Psomopoulos Fotis13ORCID,Carriles Alejandra A.4ORCID,Gounari Maria1,Minici Claudia4ORCID,Plevova Karla56ORCID,Sutton Lesley-Ann3,Tsagiopoulou Maria1ORCID,Baliakas Panagiotis7,Pasentsis Kostas1,Anagnostopoulos Achilles8ORCID,Sandaltzopoulos Raphael2,Rosenquist Richard39,Davi Frederic10ORCID,Pospisilova Sarka56ORCID,Ghia Paolo1112ORCID,Stamatopoulos Kostas13,Degano Massimo4,Chatzidimitriou Anastasia13

Affiliation:

1. Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece;

2. Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece;

3. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;

4. Biocrystallography Unit, Division of Immunology, Transplantation and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy;

5. Hematology and Oncology, Department of Internal Medicine, University Hospital Brno, Brno, Czech Republic;

6. Faculty of Medicine, Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic;

7. Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden;

8. Hematopoietic Cell Transplantation Unit, Department of Hematology, G. Papanikolaou Hospital, Thessaloniki, Greece;

9. Clinical Genetics, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden;

10. Department of Hematology, Hôpital Pitié-Salpêtrière and Sorbonne University, Paris, France;

11. Medical Oncology, Università Vita-Salute San Raffaele, Milan, Italy; and

12. Strategic Research Program on CLL, B Cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy

Abstract

Abstract Chronic lymphocytic leukemia (CLL) major stereotyped subset 2 (IGHV3-21/IGLV3-21, ∼2.5% of all cases of CLL) is an aggressive disease variant, irrespective of the somatic hypermutation (SHM) status of the clonotypic IGHV gene. Minor stereotyped subset 169 (IGHV3-48/IGLV3-21, ∼0.2% of all cases of CLL) is related to subset 2, as it displays a highly similar variable antigen-binding site. We further explored this relationship through next-generation sequencing and crystallographic analysis of the clonotypic B-cell receptor immunoglobulin. Branching evolution of the predominant clonotype through intraclonal diversification in the context of ongoing SHM was evident in both heavy and light chain genes of both subsets. Molecular similarities between the 2 subsets were highlighted by the finding of shared SHMs within both the heavy and light chain genes in all analyzed cases at either the clonal or subclonal level. Particularly noteworthy in this respect was a ubiquitous SHM at the linker region between the variable and the constant domain of the IGLV3-21 light chains, previously reported as critical for immunoglobulin homotypic interactions underlying cell-autonomous signaling capacity. Notably, crystallographic analysis revealed that the IGLV3-21–bearing CLL subset 169 immunoglobulin retains the same geometry and contact residues for the homotypic intermolecular interaction observed in subset 2, including the SHM at the linker region, and, from a molecular standpoint, belong to a common structural mode of autologous recognition. Collectively, our findings document that stereotyped subsets 2 and 169 are very closely related, displaying shared immunoglobulin features that can be explained only in the context of shared functional selection.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3